Quagen Company Profile
✉ Email this page to a colleague
What is the competitive landscape for QUAGEN, and what generic and branded alternatives to QUAGEN drugs are available?
QUAGEN has twenty-five approved drugs.
Drugs and US Patents for Quagen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Quagen | FLUOCINOLONE ACETONIDE | fluocinolone acetonide | OIL;TOPICAL | 212761-001 | Apr 2, 2021 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Quagen | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | SOLUTION;ORAL | 213567-002 | Jun 4, 2020 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Quagen | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE | codeine phosphate; promethazine hydrochloride | SYRUP;ORAL | 214238-001 | Oct 8, 2020 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.